Note: Single-source report; awaiting corroboration.
A study published in the CDC's Emerging Infectious Diseases journal examines adverse outcomes for U.S. residents who traveled for cosmetic procedures, both internationally and within the country. Reviewing 2,162 CDC consultations from 2014 to 2024, the study identified 34 consultations related to medical travel, involving about 145 patients with complications including infections and deaths after surgeries such as liposuction, abdominoplasty, breast augmentation, and gluteal augmentation.
Infections were reported in 20 consultations, with 12 being suspected or confirmed nontuberculous mycobacteria cases. Most affected patients had procedures at surgery centers or clinics, and four consultations involved patient deaths. Investigations at both domestic and international centers found significant lapses in infection prevention and control—such as poor cleaning, inadequate use of personal protective equipment, deficient hand hygiene, and improper reprocessing of surgical equipment.
Kiara McNamara, CDC nurse epidemiologist and lead author, emphasized the importance of patients being informed and consulting healthcare professionals before undergoing cosmetic procedures abroad. The CDC stresses the need for stronger surveillance, improved collaboration among healthcare providers and public health agencies, and better patient education to identify adverse outcomes early and implement prevention strategies.
More information about risks related to travel-associated cosmetic procedures and patient safety is available on the CDC official website.